Renata Nacasaki Silvestre

Renata Nacasaki Silvestre

Auto-generated profile, based on publicly available information

Renata Nacasaki Silvestre

Center for Cell-Based Therapy CTC, Regional Blood Center of Ribeirão Preto, University of São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2016 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
FSFlávia G. Saliba
Flávia G. Saliba
NANatanael S. Adiwardana
Natanael S. Adiwardana
EUEliane U. Uehara
Eliane U. Uehara
RSRenata N. Silvestre
Renata N. Silvestre
VLVictor V. Leite
Victor V. Leite
JGJuliana I.F. De Gobbi
Juliana I.F. De Gobbi
This study was designed to correlate entertainment of clown-doctors (CD) activities on hospitalized children and aphysiological biomarker. For this purpose we collected saliva samples and verified children satisfaction with these activities by using a visual analog scale (VAS). Children from 6 to 7 years-old, with diagnosis of any acute pathology, interned in the Pediatric Ward of the Botucatu Medical School Hospital (São Paulo, Brazil) were interviewed. Two groups were taken into consideration: lunchCD and dinnerCD. The following protocol was applied in each group (lunch and dinner): collection of the first saliva sample and presentation of VAS prior to CD activities, followed by collection of a second saliva sample and another VAS assessment after CD activities. The salivary cortisol was reduced in both groups comparing the first saliva sample. The satisfaction of the intervention was evident for lunchCD. The CD intervention is effective in decreasing an important physiological biomarker of stress factor, cortisol, in hospitalized children, been effective for the healing process.

6 June 2024 in Cytotherapy
Verified
Journal Article
Open access
ABAlison Felipe Bordini Biggi
Alison Felipe Bordini Biggi
RSRenata Nacasaki Silvestre
Renata Nacasaki Silvestre
MTMariane Cariati Tirapelle
Mariane Cariati Tirapelle
JAJulia Teixeira Cottas de Azevedo
Julia Teixeira Cottas de Azevedo
HGHenry David Mogollón García
Henry David Mogollón García
VPVirginia Picanço-Castro
Virginia Picanço-Castro
Chimeric antigen receptor (CAR) engineering of natural killer (NK) cells has shown promising results in early-phase clinical studies. However, advancing CAR-NK cell therapeutic efficacy is imperative. In this study, we investigated the impact of a fourth-generation CD19-targeted CAR (CAR.19) coexpressing IL-27 on NK-92 cells. We observed a significant improvement in NK-92 cell proliferation and cytotoxicity activity against B-cell cancer cell lines, both in vitro and in a xenograft mouse B-cell lymphoma model. Our systematic transcriptome analysis of the activated NK-92 CAR variants further supports the potential of IL-27 in fourth-generation CARs to overcome limitations of NK cell-based targeted tumor therapies by providing essential growth and activation signals. Integrating IL-27 into CAR-NK cells emerges as a promising strategy to enhance their therapeutic potential and elicit robust responses against cancer cells. These findings contribute substantially to the mounting evidence supporting the potential of fourth-generation CAR engineering in advancing NK cell-based immunotherapies.

20 July 2015 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
ASAnnie Cristhine Moraes Sousa‐Squiavinato
Annie Cristhine Moraes Sousa‐Squiavinato
RSRenata Nacasaki Silvestre
Renata Nacasaki Silvestre
DODeilson Elgui De Oliveira
Deilson Elgui De Oliveira

25 May 2022 in Cytotherapy
Verified
Journal Article
Closed access
MTMariane Cariati Tirapelle
Mariane Cariati Tirapelle
ALAna Luiza Oliveira Lomba
Ana Luiza Oliveira Lomba
RSRenata Nacasaki Silvestre
Renata Nacasaki Silvestre
AMAmanda Mizukami
Amanda Mizukami
DCDimas Tadeu Covas
Dimas Tadeu Covas
Kamilla SwiechKamilla Swiech
Kamilla Swiech